{
  "node_id": "eu-falsified-medicines-directive-2011-62-ec",
  "title": "Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 on the prevention of the entry into the legal supply chain of falsified medicinal products for human use, amending Directive 2001/83/EC and Regulation (EC) No 726/2004 of the European Parliament and of the Council and repealing Directive 2004/27/EC",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-04-21",
  "bluf": "This directive mandates that all prescription medicines placed on the EU market must bear a unique identifier (UI) and tamper-evident feature (TEF), with verification at the point of dispensing…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "nist_framework",
      "iso_standard",
      "industry_mapping",
      "ai_overlay_2026"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "eu-gmp-annex-1-sterile-manufacture-2022",
    "ich-q10-pharmaceutical-quality-system-2008"
  ],
  "primary_citations_count": 5,
  "workflow_steps_count": 8,
  "schema_fields_count": 10,
  "citation_preview": [
    "Directive 2011/62/EU, Article 1 - Amendments to Directive 2001/83/EC concerning prevention of falsified medicinal products",
    "Directive 2001/83/EC, Article 54a - Safety features for medicinal products for human use"
  ]
}